Limits...
Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3 inflammasome.

Liu W, Gu J, Qi J, Zeng XN, Ji J, Chen ZZ, Sun XL - J. Cell. Mol. Med. (2015)

Bottom Line: Paclitaxel is generally used to treat cancers in clinic as an inhibitor of cell division.We found that the combination of paclitaxel and lentinan resulted in a significantly stronger inhibition on A549 cell proliferation than paclitaxel treatment alone.In addition, combination of paclitaxel and lentinan could activate apoptosis signal regulating kinase-1 (ASK1)/p38 mitogen-activated protein kinase (MAPK) signal which also contributed to cell apoptosis.

View Article: PubMed Central - PubMed

Affiliation: Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, China.

No MeSH data available.


Related in: MedlinePlus

Schematic of the proposed mechanism involved in co-treatment with paclitaxel with letinan-induced cell apoptosis. Combination of paclitaxel and letinan induces ROS over-production, and activates NLRP3 inflammasome and ASK1/p38 MAPK signal, which are contributed to cell apoptosis. ROS: reactive oxygen species; ASK1: apoptosis signal regulating kinase-1; MAPK: mitogen-activated protein kinase; TRX: thioredoxin; TXNIP: thioredoxin-interacting protein.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4549045&req=5

fig07: Schematic of the proposed mechanism involved in co-treatment with paclitaxel with letinan-induced cell apoptosis. Combination of paclitaxel and letinan induces ROS over-production, and activates NLRP3 inflammasome and ASK1/p38 MAPK signal, which are contributed to cell apoptosis. ROS: reactive oxygen species; ASK1: apoptosis signal regulating kinase-1; MAPK: mitogen-activated protein kinase; TRX: thioredoxin; TXNIP: thioredoxin-interacting protein.

Mentions: In conclusion, co-treatment with paclitaxel and lentinan plays a synergistic role in enhancing A549 cell apoptosis. Activations of ROS-TXNIP-NLRP3 inflammasome and ASK1/p38 MAPK signal pathways contributed to these synergistic effects (as shown in Fig.7). Our results suggest that combined therapy with paclitaxel and lentinan may have a potential clinical perspective in cancer treatments.


Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3 inflammasome.

Liu W, Gu J, Qi J, Zeng XN, Ji J, Chen ZZ, Sun XL - J. Cell. Mol. Med. (2015)

Schematic of the proposed mechanism involved in co-treatment with paclitaxel with letinan-induced cell apoptosis. Combination of paclitaxel and letinan induces ROS over-production, and activates NLRP3 inflammasome and ASK1/p38 MAPK signal, which are contributed to cell apoptosis. ROS: reactive oxygen species; ASK1: apoptosis signal regulating kinase-1; MAPK: mitogen-activated protein kinase; TRX: thioredoxin; TXNIP: thioredoxin-interacting protein.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4549045&req=5

fig07: Schematic of the proposed mechanism involved in co-treatment with paclitaxel with letinan-induced cell apoptosis. Combination of paclitaxel and letinan induces ROS over-production, and activates NLRP3 inflammasome and ASK1/p38 MAPK signal, which are contributed to cell apoptosis. ROS: reactive oxygen species; ASK1: apoptosis signal regulating kinase-1; MAPK: mitogen-activated protein kinase; TRX: thioredoxin; TXNIP: thioredoxin-interacting protein.
Mentions: In conclusion, co-treatment with paclitaxel and lentinan plays a synergistic role in enhancing A549 cell apoptosis. Activations of ROS-TXNIP-NLRP3 inflammasome and ASK1/p38 MAPK signal pathways contributed to these synergistic effects (as shown in Fig.7). Our results suggest that combined therapy with paclitaxel and lentinan may have a potential clinical perspective in cancer treatments.

Bottom Line: Paclitaxel is generally used to treat cancers in clinic as an inhibitor of cell division.We found that the combination of paclitaxel and lentinan resulted in a significantly stronger inhibition on A549 cell proliferation than paclitaxel treatment alone.In addition, combination of paclitaxel and lentinan could activate apoptosis signal regulating kinase-1 (ASK1)/p38 mitogen-activated protein kinase (MAPK) signal which also contributed to cell apoptosis.

View Article: PubMed Central - PubMed

Affiliation: Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, China.

No MeSH data available.


Related in: MedlinePlus